No Data
Express News | CEL-SCI Corp: On November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer
CEL-SCI, FDA Agree on Patient Selection Approach for Multikine Study
U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025
CEL-SCI Files to Sell 1M Shares of Common Stock for Holders
CEL-SCI Announces The Potential Impact On The Clinical Development Of Its Immunotherapy Multikine Resulting From A Recent U.S. FDA Oncologic Drugs Advisory Committee Meeting; Multikine Has Shown Survival Benefit And Favorable Safety Profile In A...
CEL-SCI Announces Potential Impact on Multikine Following FDA ODAC Meeting
151618995 : gotta look at ZENA it will be worth thousands
Stock_Drift OP 151618995 : I was trading $ZenaTech (ZENA.US)$ before you were born. But yesterday my Zena was $Hyperscale Data (GPUS.US)$ and man did it Zena!!!!!!
Guess what my Zena is today?
EZ_money Stock_Drift OP :
F HALE 151618995 : did Browie tell you that?